...
首页> 外文期刊>Biochimica et biophysica acta. Biomembranes >Surface behavior of peptides from E1 GBV-C protein: Interaction with anionic model membranes and importance in HIV-1 FP inhibition
【24h】

Surface behavior of peptides from E1 GBV-C protein: Interaction with anionic model membranes and importance in HIV-1 FP inhibition

机译:E1 GBV-C蛋白的肽的表面行为:与阴离子模型膜的相互作用以及对HIV-1 FP抑制的重要性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The interaction between a peptide sequence from GB virus C El protein (E1P8) and its structural analogs (E1P8-12), (E1P8-13), and (E1P8-21) with anionic lipid membranes (POPG vesicles and POPG, DPPG or DPPC/DPPG (2:1) monolayers) and their association with HIV-1 fusion peptide (HIV-1 FP) inhibition at the membrane level were studied using biophysical methods. All peptides showed surface activity but leakage experiments in vesicles as well as insertion kinetics in monolayers and lipid/peptide miscibility indicated a low level of interaction: neither E1P8 nor its analogs induced the release of vesicular content and the exclusion pressure values (pi(e)) were clearly lower than the biological membrane pressure (24-30 mN m(-1)) and the HIV-1 FP (35 mN m(-1)). Miscibility was elucidated in terms of the additivity rule and excess free energy of mixing (G(E)). E1P8, E1P8-12 and E1P8-21 (but not E1P8-13) induced expansion of the POPG monolayer. The mixing process is not thermodynamically favored as the positive G(E) values indicate. To determine how El peptides interfere in the action of HIV-1 FP at the membrane level, mixed monolayers of HIV-1 FP/E1 peptides (2:1) and POPG were obtained. E1P8 and its derivative E1P8-21 showed the greatest HIV-1 FP inhibition. The LC-LE phase lipid behavior was morphologically examined via fluorescence microscopy (FM) and atomic force microscopy (AFM). Images revealed that the E1 peptides modify HIV-1 FP-lipid interaction. This fact may be attributed to a peptide/peptide interaction as indicated by AFM results. Finally, hemolysis assay demonstrated that El peptides inhibit HIV-1 FP activity. (C) 2014 Elsevier B.V. All rights reserved.
机译:GB病毒C El蛋白的肽序列(E1P8)及其结构类似物(E1P8-12),(E1P8-13)和(E1P8-21)与阴离子脂质膜(POPG囊泡和POPG,DPPG或DPPC)之间的相互作用使用生物物理方法研究了/ DPPG(2:1)单层膜及其在膜水平上与HIV-1融合肽(HIV-1 FP)抑制的关系。所有肽均表现出表面活性,但在囊泡中的渗漏实验以及在单层中的插入动力学和脂质/肽的混溶性表明相互作用水平较低:E1P8及其类似物均未诱导囊泡内容物的释放和排阻压力值(pi(e) )明显低于生物膜压力(24-30 mN m(-1))和HIV-1 FP(35 mN m(-1))。根据可加性规则和混合的多余自由能(G(E))阐明了混溶性。 E1P8,E1P8-12和E1P8-21(但不是E1P8-13)引起POPG单层的膨胀。正G(E)值表明,混合过程在热力学上不受欢迎。为了确定E1肽如何在膜水平上干扰HIV-1 FP的作用,获得了HIV-1 FP / E1肽(2:1)和POPG的混合单层。 E1P8及其衍生物E1P8-21对HIV-1 FP的抑制作用最大。 LC-LE相脂质行为通过荧光显微镜(FM)和原子力显微镜(AFM)进行了形态学检查。图像显示E1肽可修饰HIV-1 FP-脂质相互作用。如AFM结果所示,该事实可归因于肽/肽相互作用。最后,溶血测定法证明E1肽抑制HIV-1 FP活性。 (C)2014 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号